Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion.
about
Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient miceObesity pharmacotherapy: current perspectives and future directionsObesity treatment: novel peripheral targets.Role of cholecystokinin in appetite control and body weight regulation.The vagus nerve, food intake and obesity.Regulating food intake.Modulation of appetite by gonadal steroid hormones.Gut hormones as potential new targets for appetite regulation and the treatment of obesity.CCK(1) receptor is essential for normal meal patterning in mice fed high fat dietDeficits in gastrointestinal responses controlling food intake and body weight.Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity.Early postnatal overnutrition: potential roles of gastrointestinal vagal afferents and brain-derived neurotrophic factor.Vagal afferent controls of feeding: a possible role for gastrointestinal BDNF.Understanding synergy.Low-dose leptin infusion in the fourth ventricle of rats enhances the response to third-ventricle leptin injection.A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.Regulation of leptin distribution between plasma and cerebrospinal fluid by cholecystokinin receptors.Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats.Peptides that regulate food intake: norepinephrine is not required for reduction of feeding induced by cholecystokinin.Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients.
P2860
Q24644715-85EB16E6-DF1C-4349-8CEC-03516F5383D2Q26828559-1B819928-B225-45AC-9BB1-8DE0E2CC0443Q33607971-D52E2FEB-C18E-445C-BFF7-1AF23175C861Q34462432-6B4113E7-8B28-49C9-ABC0-B406630F322AQ34778864-E60D1704-9FC2-460F-A0FA-EDA2D1B58FECQ35061523-0693B5E5-FB8D-49C4-8301-61DDC9BFD742Q35140236-65345625-EF24-4906-869D-5718ACC25AA7Q37057996-31878040-5B83-4C12-8030-48AEC51737E2Q37175144-353161E3-1F77-40E4-80CC-7B216589188DQ37791290-154B27C0-49BA-4E21-9628-B8FDCAA00FF4Q37992743-07D37052-AF6C-4D87-AD7D-87665D8EA4C4Q38019927-AF5B952C-F603-421C-A8D8-EB6EA6AE7D72Q38020318-54F65F2F-1C06-4DBA-8E58-A8170BA2CBDBQ38065010-B8944812-473F-45CC-B4F6-1C728CB66720Q38820162-DA7993D0-2997-4297-AE41-AA0D684B01FBQ39873495-F67DA554-1E81-4B5A-8F0C-C38AE1B5047BQ43263217-E2917C60-6056-411F-95A3-6283D8ACF1C3Q44214905-53154AE4-1CE0-481D-86FE-D36D7FFCC63DQ44433230-37FAF6DD-9FBB-4873-90D7-93B3AF2C801EQ47281817-D987A230-1252-4D04-9684-1DEF074C98AB
P2860
Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Daily CCK injection enhances r ...... roventricular leptin infusion.
@en
Daily CCK injection enhances r ...... roventricular leptin infusion.
@nl
type
label
Daily CCK injection enhances r ...... roventricular leptin infusion.
@en
Daily CCK injection enhances r ...... roventricular leptin infusion.
@nl
prefLabel
Daily CCK injection enhances r ...... roventricular leptin infusion.
@en
Daily CCK injection enhances r ...... roventricular leptin infusion.
@nl
P2093
P2860
P1476
Daily CCK injection enhances r ...... roventricular leptin infusion.
@en
P2093
Claire A Matson
Dana F Reid
Robert C Ritter
P2860
P304
P356
10.1152/AJPREGU.00080.2001
P577
2002-05-01T00:00:00Z